Tabula Rasa HealthCare
15
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
5 terminated/withdrawn out of 15 trials
54.5%
-32.0% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Implementation of a Pharmacist-led Pharmacogenomic Clinical Service
Role: lead
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy
Role: lead
Type 2 Diabetes With Antiplatelet Drugs
Role: lead
Hospice Quality Score Assessment Post Pharmacist Intervention
Role: lead
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations
Role: lead
Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications
Role: lead
Pharmacist-led Interventions to Improve Medication Use
Role: lead
Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting
Role: lead
Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly
Role: lead
Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study
Role: lead
LACE+ and MRS Score Readmission Rate Assessment
Role: lead
Characteristics and Clinical Implications of a Clinical Decision Support System
Role: collaborator
The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)
Role: lead
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
Role: lead
Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice
Role: lead
All 15 trials loaded